Fang Wu

3.0k total citations
112 papers, 1.9k citations indexed

About

Fang Wu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Fang Wu has authored 112 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 39 papers in Pulmonary and Respiratory Medicine and 35 papers in Molecular Biology. Recurrent topics in Fang Wu's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Diagnosis and Treatment (21 papers) and Lung Cancer Research Studies (17 papers). Fang Wu is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Diagnosis and Treatment (21 papers) and Lung Cancer Research Studies (17 papers). Fang Wu collaborates with scholars based in China, United States and Canada. Fang Wu's co-authors include Chunhong Hu, Yue Zeng, Junqi Liu, Yue Pan, Xiaohan Liu, Chenghui Cao, Guyi Wang, Guobao Wu, Chenfang Wu and Jianlei Lv and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Fang Wu

100 papers receiving 1.8k citations

Peers

Fang Wu
Furong Zeng China
Huabing Tan China
Xiangning Fu China
Guangtong Deng China
Bin Sun China
Xueqin Chen China
Marc A. Schneider Germany
Ruiguang Zhang China
Jun Lin China
Furong Zeng China
Fang Wu
Citations per year, relative to Fang Wu Fang Wu (= 1×) peers Furong Zeng

Countries citing papers authored by Fang Wu

Since Specialization
Citations

This map shows the geographic impact of Fang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Wu more than expected).

Fields of papers citing papers by Fang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Wu. The network helps show where Fang Wu may publish in the future.

Co-authorship network of co-authors of Fang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Fang Wu. A scholar is included among the top collaborators of Fang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang Wu. Fang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shaoqing, Yanzhao Zhou, Fang Wu, et al.. (2025). PLAUR + Neutrophils Drive Anti‐PD‐1 Therapy Resistance in Patients with Hepatocellular Carcinoma by Shaping an Immunosuppressive Microenvironment. Advanced Science. 12(38). e07167–e07167. 2 indexed citations
2.
3.
4.
Zeng, Yuan, Xue Jiang, Lihao Zhao, et al.. (2024). Ketogenesis attenuated KLF5 disrupts iron homeostasis via LIF to confer oxaliplatin vulnerability in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(6). 167210–167210. 6 indexed citations
5.
Xue, He, Fang Wu, Qingchun Liang, et al.. (2024). Confronting synchronous multiple primary lung cancers: Navigating the intersection of challenges and opportunities. Lung Cancer. 197. 107994–107994. 1 indexed citations
6.
Wu, Fang, et al.. (2024). RARB associated with MSI, affects progression and prognosis of gastric cancer. BMC Gastroenterology. 24(1). 285–285. 1 indexed citations
7.
8.
Zeng, Yue, Xingxiang Pu, Fengjiao He, et al.. (2024). The efficacy of postoperative radiotherapy in resected pⅢA-N2 EGFR mutant and wild-type lung adenocarcinoma. iScience. 27(7). 110219–110219.
9.
Yu, Fenglei, Xiaojie Huang, Zhenyu Zhao, et al.. (2023). Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer. Clinical Epigenetics. 15(1). 4–4. 8 indexed citations
10.
Zheng, Nan, Yimin Zhang, Qiang Ma, et al.. (2023). Pathological Response and Tumor Immune Microenvironment Remodeling Upon Neoadjuvant ALK-TKI Treatment in ALK-Rearranged Non-Small Cell Lung Cancer. Targeted Oncology. 18(4). 625–636. 5 indexed citations
11.
Wang, Shuxing, Zhuqing Liu, Wentao Tian, et al.. (2023). Efficacy and safety of first-line immune checkpoint inhibitors combined with chemotherapy for extensive-stage small cell lung cancer: A network meta-analysis. Lung Cancer. 178. 47–56. 24 indexed citations
12.
Hu, Chunhong, Long Shu, Chen Chen, et al.. (2022). A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection. Translational Lung Cancer Research. 11(1). 24–42. 9 indexed citations
13.
Hu, Yan, Siying Ren, Chao Zeng, et al.. (2021). Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer. Frontiers in Oncology. 11. 684070–684070. 12 indexed citations
14.
Hu, Chunhong, Xiaohan Liu, Yue Zeng, Junqi Liu, & Fang Wu. (2021). DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application. Clinical Epigenetics. 13(1). 166–166. 157 indexed citations
15.
Gao, Shen, et al.. (2020). CASC11 Overexpression Predicts Poor Prognosis and Regulates Cell Proliferation and Apoptosis in Ovarian Carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Li, Quan, et al.. (2020). Comprehensive Analysis of CDC27 Related to Peritoneal Metastasis by Whole Exome Sequencing in Gastric Cancer. SHILAP Revista de lepidopterología. 2 indexed citations
17.
Zhong, Yanjun, Lishu Zhao, Guobao Wu, et al.. (2020). Impact of renin–angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study. Journal of International Medical Research. 48(12). 1220778703–1220778703. 15 indexed citations
18.
Liu, Yuying, Fen Qin, Changqing Cao, et al.. (2019). Electrospun Poly (Aspartic Acid)-Modified Zein Nanofibers for Promoting Bone Regeneration. SHILAP Revista de lepidopterología. 1 indexed citations
19.
20.
Wu, Fang, et al.. (2007). [Herceptin plus adjuvant chemotherapy for the prognosis of patients with human epithelial growth factor receptor 2 positive early-stage breast cancer: a meta-analysis].. PubMed. 32(4). 684–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Furong Zeng Breakdown of academic impact, for papers by Huabing Tan Breakdown of academic impact, for papers by Xiangning Fu Breakdown of academic impact, for papers by Guangtong Deng Breakdown of academic impact, for papers by Bin Sun Breakdown of academic impact, for papers by Xueqin Chen Breakdown of academic impact, for papers by Marc A. Schneider Breakdown of academic impact, for papers by Ruiguang Zhang Breakdown of academic impact, for papers by Jun Lin
Rankless by CCL
2026